First Tracks Biotherapeutics Inc (TRAX)
TRAX Stock Price Chart
Explore First Tracks Biotherapeutics Inc interactive price chart. Choose custom timeframes to analyze TRAX price movements and trends.
TRAX Company Profile
Discover essential business fundamentals and corporate details for First Tracks Biotherapeutics Inc (TRAX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Apr 2026
Employees
104.00
Website
https://www.firsttracksbio.comCEO
Daniel R. Faga
Description
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
TRAX Financial Timeline
Browse a chronological timeline of First Tracks Biotherapeutics Inc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 7 Aug 2026
EPS estimate is -$0.80, while revenue estimate is $75.00m.
TRAX Stock Performance
Access detailed TRAX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
